demonstrated that MMP11 can activate the insulin-like growth factor 1 (IGF-1)/protein kinase B (AKT)/forkhead box protein O1 (FoxO1) signaling pathway in a series of preclinical mouse mammary tumor models, thereby affecting tumor metabolism and promoting cancer growth (54). This evidence concerns the gene FOXO1 and cancer.